ALEXANDRIA, Va., June 16 -- United States Patent no. 12,305,171, issued on May 20, was assigned to bioAffinity Technologies Inc. (San Antonio).
"Compositions and methods for treating cancer" was invented by David J. Elzi (San Antonio), William E. Bauta (San Antonio) and Vivienne I. Rebel (San Antonio).
According to the abstract* released by the U.S. Patent & Trademark Office: "A double stranded RNA interference (RNAi) agent comprising at least one of (i) a first double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a CD320 gene wherein the first dsRNA comprises a sense strand an antisense strand forming a duplex, (ii) a second dsRNA for inhibiting the expression of a LRP2 gene wherein the second dsRNA comprises a sense...